Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair.

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[2]  K. Tobita,et al.  Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. , 2009, Biomaterials.

[3]  Xian‐Zheng Zhang,et al.  Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction. , 2009, Journal of biomedical materials research. Part A.

[4]  Tong Hao,et al.  Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.

[5]  Randall J. Lee,et al.  The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. , 2009, Biomaterials.

[6]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[7]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[8]  Xian‐Zheng Zhang,et al.  Novel thermosensitive hydrogel injection inhibits post‐infarct ventricle remodelling , 2009, European journal of heart failure.

[9]  Julie A. Phillippi,et al.  Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. , 2008, Journal of the American College of Cardiology.

[10]  M. Gnecchi,et al.  Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.

[11]  R. Guyton,et al.  Abstract 1847: Modulation of Cardiac Remodeling with Acellular Matrix Emulsion is Associated with Myofibroblast Proliferation and Angiogenesis via Recruiting C-Kit Positive Cells after Myocardial Infarction , 2008 .

[12]  S. Berceli,et al.  071 Connective Tissue Growth Factor (CTGF) Content and Bioactivity of Small Intestinal Submucosa (SIS) , 2008 .

[13]  Smadar Cohen,et al.  Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat , 2008, Circulation.

[14]  Stephen F Badylak,et al.  The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.

[15]  David J Mooney,et al.  Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.

[16]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[17]  Randall J Lee,et al.  Biomaterials for the treatment of myocardial infarction. , 2006, Journal of the American College of Cardiology.

[18]  Richard T. Lee,et al.  Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. , 2005, The Journal of clinical investigation.

[19]  Johnny Huard,et al.  Differential myocardial infarct repair with muscle stem cells compared to myoblasts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  N. Smedira,et al.  Small Intestinal Submucosa Intracardiac Patch: An Experimental Study , 2005, Surgical innovation.

[21]  Theo Kofidis,et al.  Novel Injectable Bioartificial Tissue Facilitates Targeted, Less Invasive, Large-Scale Tissue Restoration on the Beating Heart After Myocardial Injury , 2005, Circulation.

[22]  K. Christman,et al.  Pleiotrophin induces formation of functional neovasculature in vivo. , 2005, Biochemical and biophysical research communications.

[23]  S. Badylak,et al.  Extracellular matrix for myocardial repair. , 2005, The heart surgery forum.

[24]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[25]  Ching-Pin Chang,et al.  Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. , 2004, The Journal of thoracic and cardiovascular surgery.

[26]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[27]  Randall J Lee,et al.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.

[28]  J. Schalken,et al.  A rabbit model to tissue engineer the bladder. , 2004, Biomaterials.

[29]  Masashi Komeda,et al.  Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model , 2003, Heart and Vessels.

[30]  S. Badylak,et al.  Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. , 2002, Biomaterials.

[31]  Jason Hodde,et al.  Naturally occurring scaffolds for soft tissue repair and regeneration. , 2002, Tissue engineering.

[32]  Dusan Pavcnik,et al.  Percutaneous bioprosthetic venous valve: a long-term study in sheep. , 2002, Journal of vascular surgery.

[33]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[34]  E. Cheng,et al.  Urologic tissue engineering with small-intestinal submucosa: potential clinical applications , 2000, World Journal of Urology.

[35]  S. Badylak,et al.  Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold. , 1999, Biomaterials.

[36]  S. Badylak,et al.  Identification of extractable growth factors from small intestinal submucosa , 1997, Journal of cellular biochemistry.

[37]  L A Geddes,et al.  Small intestinal submucosa as a large diameter vascular graft in the dog. , 1989, The Journal of surgical research.

[38]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[39]  J. Leor,et al.  The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. , 2009, Biomaterials.

[40]  M. Chancellor,et al.  Advances toward tissue engineering for the treatment of stress urinary incontinence. , 2004, Reviews in urology.